Evidence map›Paper›PMID 40149970›Full record

ReviewBiomolecules2025

Chemotaxis and Related Signaling Systems in

Fuga Omori, Hirotaka Tajima, Sotaro Asaoka, So-Ichiro Nishiyama, Yoshiyuki Sowa, Ikuro Kawagishi

Abstract readReview
In one paragraph

Review in Biomolecules, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Distinct PlzC mechanisms integrate chemotaxis and c-di-GMP signaling to regulateProceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  4. Microorganisms · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Fuga OmoriDepartment of Frontier Bioscience, Hosei University, 3-7-2 Kajino-cho, Koganei City, Tokyo 184-8584, Japan.
Hirotaka TajimaDepartment of Frontier Bioscience, Hosei University, 3-7-2 Kajino-cho, Koganei City, Tokyo 184-8584, Japan.
Sotaro AsaokaDepartment of Frontier Bioscience, Hosei University, 3-7-2 Kajino-cho, Koganei City, Tokyo 184-8584, Japan.
So-Ichiro NishiyamaFaculty of Applied Life Science, Niigata University of Pharmacy and Medical and Life Sciences, 265-1 Higashijima, Akiha-ku, Niigata City, Niigata 956-8603, Japan.
Yoshiyuki SowaDepartment of Frontier Bioscience, Hosei University, 3-7-2 Kajino-cho, Koganei City, Tokyo 184-8584, Japan.ORCID 0000-0002-1691-2018
Ikuro KawagishiDepartment of Frontier Bioscience, Hosei University, 3-7-2 Kajino-cho, Koganei City, Tokyo 184-8584, Japan.

Funding

Japan Society for the Promotion of Science JP19K16655, JP23K06552, JP17K08842, JP23H04429, JP23K05701, JP24K10207
6 · The paper itself

Abstract

The motility and chemotaxis of

Indexed as

ChemotaxisSignal TransductionVibrio choleraeBacterial ProteinsFlagellaHistidine KinaseBacterial ProteinsHistidine Kinasebacterial flagellachemotaxisflagellar motormotilitypathogenicityreceptorsignal transductiontwo-component system

Identifiers

PMID40149970
PMCPMC11940527

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.